These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 22033022

  • 1. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.
    Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T, Yoshii H, Oyama N, Okazawa H, Saga T, Fujibayashi Y.
    Nucl Med Biol; 2012 Feb; 39(2):177-85. PubMed ID: 22033022
    [Abstract] [Full Text] [Related]

  • 2. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW.
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [Abstract] [Full Text] [Related]

  • 3. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
    Burgman P, O'Donoghue JA, Lewis JS, Welch MJ, Humm JL, Ling CC.
    Nucl Med Biol; 2005 Aug; 32(6):623-30. PubMed ID: 16026709
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM.
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [Abstract] [Full Text] [Related]

  • 5. Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).
    Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ.
    J Nucl Med; 2008 Feb; 49(2):201-5. PubMed ID: 18199612
    [Abstract] [Full Text] [Related]

  • 6. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
    Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A.
    J Nucl Med; 1997 Jul; 38(7):1155-60. PubMed ID: 9225812
    [Abstract] [Full Text] [Related]

  • 7. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
    Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ.
    J Nucl Med; 2001 Apr; 42(4):655-61. PubMed ID: 11337556
    [Abstract] [Full Text] [Related]

  • 8. Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.
    Vāvere AL, Lewis JS.
    Nucl Med Biol; 2008 Apr; 35(3):273-9. PubMed ID: 18355682
    [Abstract] [Full Text] [Related]

  • 9. Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
    Bradshaw TJ, Yip S, Jallow N, Forrest LJ, Jeraj R.
    Int J Radiat Oncol Biol Phys; 2014 Jun 01; 89(2):399-405. PubMed ID: 24685446
    [Abstract] [Full Text] [Related]

  • 10. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
    Tateishi K, Tateishi U, Sato M, Yamanaka S, Kanno H, Murata H, Inoue T, Kawahara N.
    AJNR Am J Neuroradiol; 2013 Jan 01; 34(1):92-9. PubMed ID: 22700754
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
    Dence CS, Ponde DE, Welch MJ, Lewis JS.
    Nucl Med Biol; 2008 Aug 01; 35(6):713-20. PubMed ID: 18678357
    [Abstract] [Full Text] [Related]

  • 15. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T, Yuan Q, Jin ZH, Aung W, Yoshii Y, Hasegawa S, Endo H, Inoue M, Zhang MR, Fujibayashi Y, Saga T.
    Oncol Rep; 2015 Sep 01; 34(3):1379-87. PubMed ID: 26134305
    [Abstract] [Full Text] [Related]

  • 16. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
    Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, Yoshii H, Asai T, Okazawa H, Welch MJ, Fujibayashi Y.
    Nucl Med Biol; 2011 Feb 01; 38(2):151-7. PubMed ID: 21315269
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.